Article Information
History
- January 12, 2022.
Article Versions
- You are currently viewing Version 1 of this article (January 12, 2022 - 12:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ben Nicholas1,*,
- Jane Guo2,
- Hyun-Hee Lee2,
- Alistair Bailey3,
- Rene de Waal Malefyt4,
- Milenko Cicmil2 and
- Ratko Djukanovic1
- 1Division of clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Hampshire, United Kingdom
- 2Oncology & Immunology Discovery, Merck Research Laboratories, Boston, MA, United States of America
- 3Cancer Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Hampshire, United Kingdom
- 4Merck Research Laboratories, Palo Alto, California, United States of America
- ↵*Correspondence to:
Dr Ben Nicholas, Centre for Proteomic Research, B85, Life Sciences Building, University of Southampton, University Road, Highfield, Southampton, Hants., SO17 1BJ, Tel No: +44(0)2380 59 5503; email: b.l.nicholas{at}soton.ac.uk
Posted January 12, 2022.
Analysis of cell-specific peripheral blood biomarkers in severe allergic asthma identifies innate immune dysfunction
